REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical trials for REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on lupus in first human trial
Disease control Recruiting nowThis early-stage trial tests a personalized cell therapy for adults with severe lupus that hasn't responded to standard treatments. Participants receive a single infusion of their own immune cells, re-engineered to target and destroy the faulty cells driving their disease. The st…
Matched conditions: REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
Lupus breakthrough? new injection targets immune cells
Disease control Recruiting nowThis study tests an injection called GC012F in 118 adults with refractory systemic lupus erythematosus (lupus that hasn't responded to standard treatments). The therapy aims to control the disease by targeting certain immune cells. Researchers will check safety and how well it re…
Matched conditions: REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE1, PHASE2 • Sponsor: Gracell Biotechnologies (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC